Boston Globe: Genzyme Center wins annual Parker Medal

This year's Parker winner is the Genzyme Center, the headquarters of a major biotech company, at 500 Kendall St. near MIT.

Chet ClemJanuary 18, 2009Genzyme, 500 Kendall, Parker Medal, Genzyme Center, Kendall Square

ArchitectureBoston: "Graphic Essay: The Innovative Client"

David Clem and Lyme Properties are featured in the November/December 2007 edition of ArchitectureBoston, which showcases their focus on excellent architectural work at Kendall Square. The full article can be downloaded here.

Chet ClemDecember 3, 2007Genzyme, 500 Kendall, Kendall Square, 675 West Kendall, 650 East Kendall, 450 Kendall, Genzyme Center

Genzyme Center: Shedding New Light on Sustainable Building Strategies

Chet ClemSeptember 27, 2005Genzyme, Kendall Square, 500 Kendall, LEED, Genzyme Center

Lyme Properties To Sell A Portion Of Cambridge Portfolio To BioMed Realty Trust For $524 Million

HANOVER, NEW HAMSPHIRE, April 18, 2005 - David Clem, Managing Director of Lyme Properties, announced an agreement to sell eight life science buildings and one parking garage in Cambridge, MA to BioMed Realty Trust of San Diego, California. The purchase price for the 1,150,000 square foot portfolio is $524 million, making it the largest single transaction in the history of life sciences real estate. “This transaction validates the work of Lyme for the past ten years and demonstrates the investment potential of first-class research space in well established academic centers,” said Clem.